Aims-To analyse the topographical distribution of adhesion molecules involved in lymphocyte recirculation in human lymph nodes and tonsils. The study focused on the expression of LECAM-1
(CD62L), VLA-a4 (CD49d), VLA-p1 (CD29), LFA-1 aL (CD11a), LFA-P2 (CD18), VCAM-1 (CD106), ICAM-1 (CD54), and H-CAM (CD44). Methods-Reactive lymph nodes and palatine tonsils were studied using immunofluorescence methods with fluorescein isothiocyanate (FITC) labelled monoclonal antibodies directed against cell adhesion molecules. To investigate the expression patterns of these molecules in the T and B cell populations, double labelling experiments were performed using Texas Red labelled antibodies against CD2 or CD19, respectively. The images from each fluorochrome were then simultaneously analysed using a laser scanning confocal microscope. Results-LECAM-l, VLA-a4 and H-CAM were predominantly expressed by mantle zone B cells, VCAM-1 and ICAM-1 by germinal centre cells, most of which exhibited a reticular staining pattern suggestive of follicular dendritic cells, whereas LFA-1 aL and LFA-P2 were mainly found in extrafollicular and germinal centre T cells. All high endothelial venules expressed VLA-P1 and ICAM-1, whereas VCAM-1 was present in only a few, with variable intensity.
Conclusions-The data show that all of these adhesion molecules are differentially distributed within the distinct functional microenvironments of both organs. The differences observed in the expression patterns among the B and T cells belonging to different compartments probably de- Most mature B and T lymphocytes continuously recirculate throughout secondary lymphoid organs in an exquisitely regulated and dynamic process. Naive B and T cells leave the primary lymphoid organs where they were generated, circulate in the blood and enter the secondary lymphoid organs across specialised high endothelial post-capillary venules (HEV). Later, they leave the lymphoid organs through the efferent lymph, drain into the blood, via the thoracic duct, and return to the same or another lymphoid organ.' Although adhesion to HEV seems to be a general property of all mature lymphocytes, B and T cells exhibit a marked selectivity in their migration patterns to secondary lymphoid organs, a fact that will eventually determine the functional effector cell types that predominate in each particular organ. Mucosa associated lymphoid tissues are particularly enriched in B lymphocytes, in contrast to peripheral lymph nodes where T cells make up more than two thirds of lymphoid cells.' In addition to this organ specific distribution, B and T cells show distinct compartimentalisation within lymphoid tissues. Thus, after endothelial adhesion, B Red conjugated avidin (1 jig/ml; Vector Laboratories), mouse antiavidin (5 jg/ml; Vector Laboratories) and Texas Red conjugated avidin (20,g/ml; Vector Laboratories). All sections were routinely post-fixed in 4% formaldehyde for 10 minutes before mounting. Controls were created by omitting the primary antibody to ensure the specificity of the detection systems.
For double labelling experiments, the sections were first incubated with biotinylated anti-CD2 or anti-CD19, then biotin was detected using the avidin/antiavidin amplification system and finally the sections were incubated with FITC conjugated antibodies directed against adhesion molecules. As FITC conjugated antibodies were not available for VLAoc4 and VCAM-1, we were forced to use nonconjugated ones. In this particular case, the sections were first incubated with non-conjugated antibody, then with FITC labelled goat antimouse IgG and finally, with the biotinylated antibody. Using this procedure, the staining pattern produced by each antibody was similar to that obtained in single labelling experiments.
To compare the differential expression of adhesion molecules in B and T cell populations directly, three sequential sections were used for the analysis of each adhesion molecule. The first was incubated with an antiadhesion molecule antibody, the second was double labelled for the adhesion molecule and B cells, and the third was double labelled for the adhesion molecule and T cells.
Samples were examined by the Zeiss LSM 3 The staining patterns observed permitted clear delineation of the different compartments in both lymph nodes and tonsils (table 2), in terms of their adhesion molecule profiles, although some staining heterogeneity was evident either within the same sample or between different samples from both organs. LECAM-1 (green) . Both molecules co-localise in the MZ region (yellow). B: CD2 (green) and VLA-,4 (red). Both molecules co-localise in some GC and EF cells (yellow). C: CD19 (red) and ICAM-1 (green). The GC shows co-localisation (yellow) of both molecules in a pattern suggestive offollicular dendritic cells. D: CD2 (red) and ICAM-1 (green). Co-localisation of CD2 with ICAM-1 (yellow) was found in many EF cells and in some GC cells. E: CD1 9 (red) and H-CAM (green). The co-localisation (yellow) of both molecules was found predominantly in the MZ cell population. F: CD2 (red) and H-CAM (green). Co-localisation was observed in EF cells and GC cells (yellow). Bar= 50 lm. positive) were heterogeneously stained with anti-H-CAM in all extrafollicular regions.
Thus, H-CAM is predominantly detectable in the mantle zone, extrafollicular and medullary cord B cells and also in some germinal centre T cells.
Discussion
In this study we provide an integrated view of the distribution of cell adhesion molecules in the distinct functional compartments of reactive human lymph nodes and tonsils.
To enter the extravascular space in a peripheral lymphoid organ, circulating lymphocytes must interact with specific molecules present in the plasma membrane of endothelial cells.'2 Two well characterised endothelial adhesion molecules are ICAM-1 and VCAM-1, both members of the immunoglobulin superfamily.3 ICAM-1 is constitutively expressed in the membrane of all endothelial cells,'9 whereas VCAM-1 is upregulated during endothelial cell activation.202' This is consistent with the observation that antibodies against ICAM-1 stained all blood vessels, while anti-VCAM-1 antibodies stained some but not all HEV. As anti VCAM-1 antibodies are likely to label only activated endothelial cells, this may indicate that endothelial activation is not a synchronous phenomenon in lymphoid organs.
ICAM-1 and VCAM-1 from endothelial cells bind to LFA-1 and VLA-4, respectively, on lymphocytes.3''71 The interactions between these molecules on both cell types mediate a strong, albeit transient, adhesion of lymphoid cells to the endothelium.'2 Upon adhesion of a lymphocyte to the endothelium, VLA-4 is functionally activated and upregulated and participates, together with the ICAM-1/LFA-1 pathway, in the process of diapedesis and chemotaxis of lymphocytes into the surrounding tissue.3622 Therefore, the staining produced by anti-VLA-ca4 antibodies in the mantle zone and extrafollicular regions is likely to reflect the migratory behaviour of the cells present within these compartments.
In addition to endothelial cells, the follicular dendritic cells in germinal centres also express ICAM-1 and VCAM-110 which interact with LFA-1 and VLA-4, respectively, expressed by germinal centre B cells.623 The contact between follicular dendritic cells and B lymphocytes is crucial for the terminal activation and differentiation phenomena that underlie the generation of effector and memory B cells in germinal centres.623 Accordingly, we observed that germinal centres were labelled by antibodies directed against ICAM-1, VCAM-1, LFA1-otL, and VLA-oa4.
ICAM-1 is expressed by endothelial and follicular dendritic cells, and also by T and B lymphocytes upon cell activation.'9 Therefore, the extrafollicular ICAM-1 positive cells that co-express CD2 probably represent activated T lymphocytes. However, ICAM-1 is also involved in T cell dependent B cell activation, via the ICAM-1/LFA-1 pathway,'9 and thus activated B cells may also account for the extrafollicular and medullary cord staining observed. The lack of ICAM-1 labelling in the mantle zone B cells is consistent with the quiescent state of these cells. 9 LFA-1, the counter-receptor of iCAM-1, was detected in the same compartments as ICAM-1-that is, germinal centres and extrafollicular regions, but not in HEV. Most of the LFAI-oaL positive cells co-expressed CD2 in both compartments, showing that this molecule is mainly present in T cell populations. This finding agrees with the observation that LFA-1, despite being expressed by all leucocytes and some macrophages, is more abundantly expressed on T than on B cells, and is present at higher concentrations in activated T cell blasts.24 However, it is known that isolated germinal centre B cells also express this molecule and, as previously mentioned, the ICAM-1 /LFA-1 pathway participates in follicular dendritic cell/B lymphocyte binding and in the generation of B memory cells in the germinal centres.623 In this study, co-localisation of CD19 and LFA-1 aoL was found in a few germinal centre cells. As isolated follicular dendritic cells seem to be LFA-1 negative,6 it is likely that the CD 1 9/LFA-1 aL positive cells represent activated germinal centre B lymphocytes.
The selectin LECAM-1 is expressed by most mature and recirculating naive B and T lymphocytes. 7 We observed that the mantle zone was the most intensely labelled compartment with antibodies against LECAM-1. This finding is consistent with the hypothesis that this region is mostly populated by quiescent B cells. In summary, we conclude that adhesion molecules are differentially distributed in the distinct functional compartments of both lymph nodes and tonsils. Within each compartment, the expression patterns observed in the different cell populations seem to reflect the functional involvement of adhesion molecules both in lymphocyte trafficking and in the cell to cell interactions that take place in the specialised lymphoid microenvironments.
